Fusion Pharmaceuticals Inc. Form ARS: Annual report to security holders
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-04-27: Form ARS; Period of report 2022-12-31; Description ARS; Document d447275dars.pdf.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2023-04-27 | ARS | 2022-12-31 | ARS | d447275dars.pdf |